ProStrakan Group Mergers & Acquisitions

ProStrakan Group M&A Summary

ProStrakan Group has acquired 1 company. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.

ProStrakan Group’s largest acquisition to date was in 2014, when it acquired Archimedes Pharma for $354M. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

ProStrakan Group Plc

Galabank Business Park,
Galashiels, TD1 1QH
United Kingdom,
44-0-1896-664000
www.prostrakan.com

All (2) Buy (1) Sell (1)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2014-08-06 Archimedes Pharma Ltd. · Life Science
Reading, United Kingdom · www.archimedespharma.com

Archimedes is a pharmaceutical company with an established commercial organisation in the UK, France, Germany, Ireland and Spain.

354 Add-on Acquisition

ProStrakan Group Plc

Warburg Pincus PE

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.